Ascendis Pharma Added to Multiple Russell U.S. Indexes

Ascendis Pharma (ASND) has been added to the Russell 3000, Russell 1000, Russell 2500, and Russell Midcap indexes as part of the annual reconstitution effective June 26. This inclusion may lead to increased institutional investment in the stock.

By Pratyush Thakur, SA News Editor · Seeking Alpha · June 26, 2026, 20:46 UTC

Ascendis Pharma Added to Multiple Russell U.S. Indexes

Tickers: $ASND

Topics: index inclusion stock market

Read the full article at Seeking Alpha

More World news

Nvidia CEO Jensen Huang Resigns Amid Personal Scandals and National Security Allegations CNBC · November 12, 2026, 13:51 UTC
Zenta Group Receives Nasdaq Notice Regarding Minimum Bid Price Requirement Seeking Alpha · November 12, 2026, 13:48 UTC
SoLo Funds Launches SoLo Alpha High-Yield Investment Account PR Newswire · November 12, 2026, 13:50 UTC
Artelo Biosciences Reports Third Quarter GAAP EPS of -$3.19 Seeking Alpha · November 12, 2026, 13:46 UTC
Monopar Therapeutics Reports Q3 GAAP EPS of -$0.72 in Line with Expectations Seeking Alpha · November 12, 2026, 13:48 UTC
Market Watch: Nvidia Pressure and Key Stocks NBIS, GOOG, GIS, and MANU Seeking Alpha · November 12, 2026, 13:48 UTC
Chevron Reports $10.4 Billion Third Quarter Profit Driven by High Refining Margins Motley Fool · November 12, 2026, 13:43 UTC
Replay Sports Cards Expands North Carolina Presence with New Greenville Location PR Newswire · November 12, 2026, 13:47 UTC
Linnworks Survey Reveals US E-commerce Businesses Limit AI Role to Operational Support Over Financial Control PR Newswire · November 12, 2026, 13:43 UTC
DocsInk Rebrands as TraceWell Health and Launches Integrated Care Platform PR Newswire · November 12, 2026, 13:44 UTC